Emily E. Rice
Impact in
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
-
- Antibiotic Use and Resistance
Papers in
-
- COVID-19 Clinical Research Studies 4
-
- Sexual function and dysfunction studies 2
- Co-authors
- Hannah Catherine Moore (1 shared paper)Christopher C. Blyth (1 shared paper)Roberto A. Barrero (1 shared paper)M. Bellgard (1 shared paper)Steve Donald Wilton (1 shared paper)Sue Fletcher (1 shared paper)Aileen Reghan Foley (1 shared paper)Bryan J. Lynch (1 shared paper)
- Journals
- The Lancet (3 papers)Journal of Health Psychology (1 paper)Nature Communications (1 paper)Journal of the American Medical Directors Association (1 paper)Archives of Disease in Childhood (1 paper)
- Partner nations
- CanadaAustraliaUnited Kingdom
In The Last Decade
Emily E. Rice
8 papers receiving 910 citations
Emily E. Rice's Hit Papers
Peers
Comparison fields: 5 of 70
- Infectious Diseases 708
- Applied Microbiology and Biotechnology 34
- Internal Medicine 27
- Hematology 29
- Oncology 46
Countries citing papers authored by Emily E. Rice
This map shows the geographic impact of Emily E. Rice's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily E. Rice with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily E. Rice more than expected).
Fields of papers citing papers by Emily E. Rice
This network shows the impact of papers produced by Emily E. Rice. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily E. Rice. The network helps show where Emily E. Rice may publish in the future.
Co-authors
The 16 scholars most cited alongside Emily E. Rice, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 411 |
| 2 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 3 | 2021 | 213 | |
| 4 | 2015 | 23 | |
| 5 | 2023 | 15 | |
| 6 | 2024 | 6 | |
| 7 | 2025 | 3 | |
| 8 | 2025 | 3 | |
| 9 | 2023 | 0 | |
| 10 | 2025 | 0 |
About Emily E. Rice
Emily E. Rice is a scholar working on Infectious Diseases, Psychiatry and Mental health, Urology, Public Health, Environmental and Occupational Health and Epidemiology, having authored 10 papers that have together received 956 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (4 papers), Sexual function and dysfunction studies (2 papers), Down syndrome and intellectual disability research (1 paper), Urinary Bladder and Prostate Research (1 paper), RNA Research and Splicing (1 paper), Respiratory viral infections research (1 paper), Palliative Care and End-of-Life Issues (1 paper) and Muscle Physiology and Disorders (1 paper). The work is most often cited by research in Infectious Diseases (708 citations), Applied Microbiology and Biotechnology (34 citations), Internal Medicine (27 citations), Hematology (29 citations) and Oncology (46 citations). Emily E. Rice has collaborated with scholars based in Canada, Australia and United Kingdom. Frequent co-authors include Hannah Catherine Moore, Christopher C. Blyth, Roberto A. Barrero, M. Bellgard, Steve Donald Wilton, Sue Fletcher, Aileen Reghan Foley, Bryan J. Lynch, Hsien Yeang Seow and Mary Scott. Their work appears in journals such as The Lancet, Journal of Health Psychology, Nature Communications, Journal of the American Medical Directors Association and Archives of Disease in Childhood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.